Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing

Qiang Cheng, Tuo Wei, Lukas Farbiak

CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis

Julian David Gillmore, Ed J. Gane, Jörg Täubel

Correction to ‘AlPaCas: allele-specific CRISPR gene editing through a protospacer-adjacent-motif (PAM) approach’

Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy

Mohammad Chehelgerdi, Matin Chehelgerdi, Matin Chehelgerdi et al.

CRISPR edits gene methylation

Gene Editing and Crop Improvement Using CRISPR-Cas9 System

Leena Arora, Alka Narula

CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia

Haydar Frangoul, David Altshuler, Maria Domenica Cappellini et al.

CRISPR-Cas9 system: A new-fangled dawn in gene editing

Darshana Gupta, Oindrila Bhattacharjee, Drishti Mandal et al.

DIPG-09. CRISPR GENE EDITING OF ENDOGENOUS MUTANT FORMS OF H3.3 DEFINES ONCOHISTONE MECHANISMS AND NEW THERAPEUTIC APPROACHES

Michael Chen, Kelly M. Bush, Rachel Herndon Klein

CRISPR in personalized medicine: Industry perspectives in gene editing

Andrew Lee Hong

Additional file 4 of Monitoring autochthonous lung tumors induced by somatic CRISPR gene editing in mice using a secreted luciferase

Nastasja Merle, Sabrina Elmshäuser, Florian Straßheimer et al.

Additional file 3 of Monitoring autochthonous lung tumors induced by somatic CRISPR gene editing in mice using a secreted luciferase

Nastasja Merle, Sabrina Elmshäuser, Florian Straßheimer et al.